A multicenter, randomized, open-label, phase 2 study of carfilzomib with or without ARRY-520 (filanesib) in patients with advanced multiple myeloma Meeting Abstract


Authors: Zonder, J. A.; Raje, N. S.; Scott, E. C.; Hofmeister, C. C.; Lendvai, N.; Anderson, L. D.; Hari, P.; Orloff, G. J.; Berdeja, J. G.; Singhal, S.; Craig, M.; Valent, J. N.; Ptaszynski, M.; Schreiber, J.; Aitchison, R.; Usmani, S. Z.
Abstract Title: A multicenter, randomized, open-label, phase 2 study of carfilzomib with or without ARRY-520 (filanesib) in patients with advanced multiple myeloma
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904874
PROVIDER: wos
Notes: Meeting Abstract: TPS8612 -- Source: Wos
MSK Authors
  1. Nikoletta Lendvai
    78 Lendvai